-
-
-
-
-
-
-
Barclays Downgrades DexCom (DXCM) to Underweight
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Jabil (JBL)
-
-
-
-
-
-
-
'DexCom (DXCM) Too Cheap to Ignore'; Stock PT Lowered at Bernstein
-
-
-
-
-
-
-
DexCom (DXCM) Mentioned Cautiously Again at Hunterbrook
-
-
-
-
-
-
-
DexCom (DXCM) options active on 24K contracts
-
-
-
-
-
-
-
DexCom (DXCM) PT Raised to $106 at UBS
-
-
-
-
-
-
-
Piper Sandler's Key MedTech Takeaways From ADA 2025
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

